How severe is CVE-2026-5779?

CVE-2026-5779 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2026-5779 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (16th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2026-5779?

CVE-2026-5779 affects Agilonhealth Minerva. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2026-5779?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

Does CVE-2026-5779 have an EU (EUVD) identifier?

Yes. CVE-2026-5779 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-26037.

When was CVE-2026-5779 published?

CVE-2026-5779 was published on 2026-04-28 and last updated on 2026-06-17.

CVE-2026-5779

CVE-2026-5779 is a high-severity vulnerability in Agilonhealth Minerva with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-284.

Key facts

Severity: High (CVSS 3.x base score 8.8)
CVSS v4: 9.4
EPSS exploit prediction: 0% (16th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2026-26037
Weakness: CWE-284
Affected product: Agilonhealth Minerva
Published: 2026-04-28
Last modified: 2026-06-17

Description

An insecure direct object reference (IDOR) vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/user/updateUserProfile' endpoint. This allows an authenticated user to modify the information of other registered users. Successful exploitation of this vulnerability allows an authenticated user to modify other users' information, such as their email address, and request a new password via the '/webconnect/#/forgotPassword' endpoint. This could lead to complete account takeover.

Frequently asked questions

What is CVE-2026-5779?: An insecure direct object reference (IDOR) vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/user/updateUserProfile' endpoint. This allows an authenticated user to modify the information of other registered users. Successful exploitation of this vulnerability allows an authenticated user to modify other users' information, such as their email address, and request a new password via the '/webconnect/#/forgotPassword' endpoint. This could lead to complete account takeover.
How severe is CVE-2026-5779?: CVE-2026-5779 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2026-5779 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (16th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-5779?: CVE-2026-5779 affects Agilonhealth Minerva. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-5779?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2026-5779 have an EU (EUVD) identifier?: Yes. CVE-2026-5779 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-26037.
When was CVE-2026-5779 published?: CVE-2026-5779 was published on 2026-04-28 and last updated on 2026-06-17.

References

https://www.incibe.es/en/incibe-cert/notices/aviso/multiple-vulnerabilities-mphrxs-minerva

Affected products (1)

cpe:2.3:a:agilonhealth:minerva:3.6.0:*:*:*:*:*:*:*

More vulnerabilities in Agilonhealth Minerva

CVE-2026-5781 — High (CVSS 8.8): An authorization vulnerability in MphRx's Minerva V3.6.0, specifically in the '/minerva/moUser/update' endpoint, could…
CVE-2026-5780 — High (CVSS 8.1): An insecure direct object reference (IDOR) vulnerability in MphRx's Minerva V3.6.0, specifically in the endpoint…

All CVEs affecting Agilonhealth Minerva →

Other CWE-284 (Improper Access Control) vulnerabilities

CVE-2026-50746 — Critical (CVSS 10.0): A malicious actor with access to the network could exploit an Improper Access Control vulnerability found in UniFi…
CVE-2026-46978 — Critical (CVSS 10.0): Vulnerability in the Oracle Solaris product of Oracle Systems (component: Remote Administration Daemon). The…
CVE-2026-35308 — Critical (CVSS 10.0): Vulnerability in the Oracle Coherence product of Oracle Fusion Middleware (component: Centralized Third Party Jars).…
CVE-2026-35307 — Critical (CVSS 10.0): Vulnerability in the Oracle Coherence product of Oracle Fusion Middleware (component: Core). Supported versions that…
CVE-2026-46695 — Critical (CVSS 10.0): Boxlite is a sandbox service that allows users to create lightweight virtual machines (Boxes) and launch OCI containers…
CVE-2026-46840 — Critical (CVSS 10.0): Vulnerability in Oracle REST Data Services (component: Backend-as-a-Service). Supported versions that are affected are…

Browse all CWE-284 (Improper Access Control) vulnerabilities →